首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2期丙型肝炎的治疗 => 专家论坛 =>与直接抗病毒药物应用相关的HCV/HBV..
与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理
Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
文章发布日期:2018年02月06日  来源:  作者:于乐成, 范晔, 李平  点击次数:615次  下载次数:169次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:HCV和HBV的双重感染(DI)具有不同于单一HCV或HBV感染的特殊临床、免疫学和病毒学特点,为临床诊治和管理带来了诸多挑战。在应用直接抗病毒药物(DAA)有效控制HCV感染的同时,可能导致HBV的激活和乙型肝炎的发作甚至肝衰竭。在抗HCV治疗的同时,根据不同的HCV/HBV-DI状态选用合适的抗HBV治疗和随访管理策略至关重要。
【Abstract】:Dual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical, immunological, and virological features from single infection with HCV or HBV, which brings various challenges to clinical diagnosis/treatment and management. Direct-acting antiviral agents used for effective control of HCV infection may cause HBV activation, onset of hepatitis B, and even liver failure. Therefore, during the antiviral treatment of HCV infection, it is of great importance to select appropriate anti-HBV therapy and follow-up management strategies based on the status of HCV/HBV dual infection.
【关键字】:肝炎病毒属; 肝炎病毒, 乙型; 重叠感染; 诊断; 治疗
【Key words】:hepacivirus; hepatitis B virus; superinfection; diagnosis; therapy
【引证本文】:YU YC, FAN Y, LI P. Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents[J]. J Clin Hepatol, 2018, 34(2): 238-241. (in Chinese)
于乐成, 范晔, 李平. 与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理[J]. 临床肝胆病杂志, 2018, 34(2): 238-241.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号